Scholarlink

Objective <p>To review recent trends in common functional urology surgery in England, using the Hospital Episode Statistics (HES) database.</p> Patients and methods <p>Data between 2013 and 2024 were obtained from the HES database, a publicly available dataset recording details about procedures in NHS England. We recorded the procedures for treatment of female stress urinary incontinence (SUI), urgency urinary incontinence (UUI), post-prostatectomy incontinence (PPI), vesicovaginal fistula (VVF) and benign prostatic enlargement (BPE) surgery.</p> Results <p>Early in the study period, the most common procedures for SUI were insertion of transobturator and tension-free vaginal tape (8319 procedures/year). We observe an almost complete halt in tape insertion and an increase in removal from 2019 (8 procedures/year), due to concerns about complications and the ‘mesh pause’ in the UK. Injection of bulking agents became the mainstream treatment from 2019 (2490 procedures/year). For refractory UUI, intravesical Botulinum toxin A (BTX) remains the preferred treatment modality (9842 procedures/year). No significant increases in neuromodulation were observed (762/year), and numbers remain low for ileocystoplasty (100/year). Transurethral Resection of the Prostate (TURP) remains the commonest operation for BPE with 15,579 cases in 2023–2024. Laser resection modalities (Holmium laser Enucleation, or HoLEP, and Photoselective Vaporization of the Prostate, or PVP) saw increases with 5098 cases in 2023–2024. VVF repair numbers remain low, averaging 83 per year. There was a reduction in overall surgical numbers during the COVID-19 pandemic, with a partial recovery from 2022 onwards.</p> Conclusion <p>Due to concerns around tape-related complications, bulking agents are now the mainstream treatment of SUI in women, and BTX in UUI. Whilst the use of laser is becoming increasingly popular, TURP remains the commonest procedure performed for BPE. There has only been a partial recovery in surgical numbers following the pandemic.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Analysis of functional urological surgery trends 2013–2024 in England using the HES database

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月14日

查看全文
  • Martina Spazzapan,
  • Rhys Evans,
  • Shubhangi Mehta,
  • Sachin Malde,
  • Arun Sahai

摘要

Objective

To review recent trends in common functional urology surgery in England, using the Hospital Episode Statistics (HES) database.

Patients and methods

Data between 2013 and 2024 were obtained from the HES database, a publicly available dataset recording details about procedures in NHS England. We recorded the procedures for treatment of female stress urinary incontinence (SUI), urgency urinary incontinence (UUI), post-prostatectomy incontinence (PPI), vesicovaginal fistula (VVF) and benign prostatic enlargement (BPE) surgery.

Results

Early in the study period, the most common procedures for SUI were insertion of transobturator and tension-free vaginal tape (8319 procedures/year). We observe an almost complete halt in tape insertion and an increase in removal from 2019 (8 procedures/year), due to concerns about complications and the ‘mesh pause’ in the UK. Injection of bulking agents became the mainstream treatment from 2019 (2490 procedures/year). For refractory UUI, intravesical Botulinum toxin A (BTX) remains the preferred treatment modality (9842 procedures/year). No significant increases in neuromodulation were observed (762/year), and numbers remain low for ileocystoplasty (100/year). Transurethral Resection of the Prostate (TURP) remains the commonest operation for BPE with 15,579 cases in 2023–2024. Laser resection modalities (Holmium laser Enucleation, or HoLEP, and Photoselective Vaporization of the Prostate, or PVP) saw increases with 5098 cases in 2023–2024. VVF repair numbers remain low, averaging 83 per year. There was a reduction in overall surgical numbers during the COVID-19 pandemic, with a partial recovery from 2022 onwards.

Conclusion

Due to concerns around tape-related complications, bulking agents are now the mainstream treatment of SUI in women, and BTX in UUI. Whilst the use of laser is becoming increasingly popular, TURP remains the commonest procedure performed for BPE. There has only been a partial recovery in surgical numbers following the pandemic.